FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

American Pharmaceutical Ingredients Estrone Recall

ESTRONE USP, packaged in a) 1g bottle (NDC: 58597-8049-2), c) 5g bottle (NDC: 58597-804…

American Pharmaceutical Ingredients LLC · Waterford, MI

Risk level
Class II
Reported by FDA
Jun 21, 2017
Recall ID
D-0919-2017
Check your lot numberHow we source this data

Summary

American Pharmaceutical Ingredients recalled Estrone starting Apr 17, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0919-2017 on Jun 21, 2017. Reason: cGMP Deviations; lack of quality assurance. Status: Terminated.

Why it was recalled

cGMP Deviations; lack of quality assurance.

Product description

ESTRONE USP, packaged in a) 1g bottle (NDC: 58597-8049-2), c) 5g bottle (NDC: 58597-8049-3), d) 25g bottle (NDC: 58597-8049-4), For Prescription Compounding, RX Only, Packed under cGMP conditions by American Pharmaceutical Ingredients, LLC, 6650 Highland Road, Waterford, MI 48327

Lot numbers, UPCs & expiration codes

Lots: 052915-1, 052915-2, exp 5/5/2017

Where it was sold

NY, GA, NV, CA, KY, TX

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0919-2017
Classification
Class II
Status
Terminated
Recall initiated
Apr 17, 2017
FDA report date
Jun 21, 2017
Quantity
1g=1 bottle; 5g=4 bottle; 25g=3 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
American Pharmaceutical Ingredients LLC

Original FDA data

Every field from FDA enforcement report D-0919-2017, exactly as published.

Show all FDA fields
City
Waterford
State
MI
Status
Terminated
Country
United States
Event ID
77465
Address
6650 Highland Rd Ste 302
Code information
Lots: 052915-1, 052915-2, exp 5/5/2017
Postal code
48327-1665
Report date
Jun 21, 2017
Product type
Drugs
Recall number
D-0919-2017
Classification
Class II
Recalling firm
American Pharmaceutical Ingredients LLC
Product quantity
1g=1 bottle; 5g=4 bottle; 25g=3 bottles
Termination date
May 31, 2018
Reason for recall
cGMP Deviations; lack of quality assurance.
Voluntary / mandated
Voluntary: Firm initiated
Product description
ESTRONE USP, packaged in a) 1g bottle (NDC: 58597-8049-2), c) 5g bottle (NDC: 58597-8049-3), d) 25g bottle (NDC: 58597-8049-4), For Prescription Compounding, RX Only, Packed under cGMP conditions by American Pharmaceutical Ingredients, LLC, 6650 Highland Road, Waterford, MI 48327
Distribution pattern
NY, GA, NV, CA, KY, TX
Recall initiation date
Apr 17, 2017
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Jun 15, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0919-2017, published Jun 21, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls